Does BICALUTAMIDE Cause Prostate cancer metastatic? 72 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Prostate cancer metastatic have been filed in association with BICALUTAMIDE (Bicalutamide). This represents 1.8% of all adverse event reports for BICALUTAMIDE.
72
Reports of Prostate cancer metastatic with BICALUTAMIDE
1.8%
of all BICALUTAMIDE reports
15
Deaths
12
Hospitalizations
How Dangerous Is Prostate cancer metastatic From BICALUTAMIDE?
Of the 72 reports, 15 (20.8%) resulted in death, 12 (16.7%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Prostate cancer metastatic Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BICALUTAMIDE. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does BICALUTAMIDE Cause?
Malignant neoplasm progression (352)
Prostatic specific antigen increased (322)
Drug ineffective (268)
Fatigue (258)
Prostate cancer (258)
Asthenia (223)
Hot flush (219)
Off label use (171)
Disease progression (169)
Anaemia (164)
What Other Drugs Cause Prostate cancer metastatic?
LEUPROLIDE (747)
ABIRATERONE (488)
DOCETAXEL (198)
ENZALUTAMIDE (165)
DENOSUMAB (144)
PREDNISONE (139)
RADIUM RA-223 DICHLORIDE (120)
CABAZITAXEL (74)
ZOLEDRONIC ACID (71)
DEXAMETHASONE (59)
Which BICALUTAMIDE Alternatives Have Lower Prostate cancer metastatic Risk?
BICALUTAMIDE vs BICTEGRAVIR
BICALUTAMIDE vs BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE
BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM
BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
BICALUTAMIDE vs BILASTINE